Why the study?
Does acute hyperglycaemia alter coronary vascular responses to nitric oxide, adenosine, and phenylephrine in isolated, perfused rat hearts?
Does acute hyperglycaemia alter coronary vascular responses to nitric oxide, adenosine, and phenylephrine in isolated, perfused rat hearts?
Acute exposure to high glucose levels does not acutely impair coronary vascular reactivity or nitric oxide bioavailability in isolated non-diabetic rat hearts.
Answers are grounded in this paper and cite their sources.
Acute hyperglycaemia leaves coronary reactivity intact in isolated rat hearts; leaves open chronic exposure or in vivo diabetes effects.
AIM: The purpose of this study was to evaluate the hypothesis that acute hyperglycaemia in hearts of rats without diabetes alters coronary vascular responses to nitric oxide (NO), adenosine (ADO) and phenylephrine (PHE). METHODS: Coronary function was studied in isolated, Langendorff-perfused, non-beating rat hearts that were perfused with an oxygenated Krebs-Henseleit solution containing 40 mM KCl to arrest the hearts. Changes in coronary vascular resistance were assessed by measuring changes in coronary perfusion pressure under constant flow conditions. Coronary responses to ADO, sodium nitroprusside (SNP), PHE and L-NAME (inhibitor of NO synthase) were studied either under normoglycaemic conditions (100 mg/dl d-glucose) or after 60 min of hyperglycaemic perfusion (500 mg/dl d-glucose). d-mannitol was used as a hyperosmotic control. RESULTS: Hyperglycaemia did not alter vasodilator responses to ADO or SNP in the presence or absence of L-NAME. Furthermore, hyperglycaemia, compared with normoglycaemia, did not alter vasoconstrictor responses induced by L-NAME or PHE. CONCLUSIONS: Sixty minutes of exposure to 500 mg/dl of d-glucose in an isolated, non-beating, buffer-perfused rat heart did not significantly affect coronary vascular smooth muscle vasodilator responses to NO and ADO or alter alpha(1)-adrenoceptor-mediated vasoconstrictor responses to PHE. Furthermore, an unchanged vasoconstrictor response to L-NAME suggests that acute hyperglycaemia did not alter NO bioavailability.
No takes yet. Share an insight, caveat, or question.
Klabunde et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: